Cite
GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level
MLA
Schro¨der, Julia, et al. “GWAS Meta-Analysis of 16 790 Patients with Barrett’s Oesophagus and Oesophageal Adenocarcinoma Identifies 16 Novel Genetic Risk Loci and Provides Insights into Disease Aetiology beyond the Single Marker Level.” Gut, vol. 72, no. 4, Jan. 2023, pp. 612–23. EBSCOhost, https://doi.org/10.1136/gutjnl-2021-326698.
APA
Schro¨der, J., Chegwidden, L., Maj, C., Gehlen, J., Speller, J., Bo¨hmer, A. C., Borisov, O., Hess, T., Kreuser, N., Venerito, M., Alakus, H., May, A., Gerges, C., Schmidt, T., Thieme, R., Heider, D., Hillmer, A. M., Reingruber, J., Lyros, O., … Schumacher, J. (2023). GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. Gut, 72(4), 612–623. https://doi.org/10.1136/gutjnl-2021-326698
Chicago
Schro¨der, Julia, Laura Chegwidden, Carlo Maj, Jan Gehlen, Jan Speller, Anne C Bo¨hmer, Oleg Borisov, et al. 2023. “GWAS Meta-Analysis of 16 790 Patients with Barrett’s Oesophagus and Oesophageal Adenocarcinoma Identifies 16 Novel Genetic Risk Loci and Provides Insights into Disease Aetiology beyond the Single Marker Level.” Gut 72 (4): 612–23. doi:10.1136/gutjnl-2021-326698.